Drug Interactions Database

944 interactions from BNF 85 - Check your medicines

Source: BNF 85
Severity: All 6278 Severe 944 Moderate 1418 Unknown 3916
stjohn’swort ivabradine

decreases exposure

Severe Study
stjohn’swort ivacaftor

decreases exposure

Severe Study
stjohn’swort ixazomib

decreases exposure

Severe Theoretical
stjohn’swort lapatinib

decreases exposure

Severe Study
stjohn’swort larotrectinib

decreases exposure

Severe Study
stjohn’swort ledipasvir

decreases exposure

Severe Study
stjohn’swort lorlatinib

decreases exposure

Severe Theoretical
stjohn’swort macitentan

decreases exposure

Severe Theoretical
stjohn’swort maraviroc

decreases exposure

Severe Theoretical
stjohn’swort midostaurin

decreases exposure

Severe Theoretical
stjohn’swort mineralocorticoidreceptorantagonists

decreases exposure

Severe Study
stjohn’swort mobocertinib

decreases exposure

Severe Study
stjohn’swort naldemedine

decreases exposure

Severe Study
stjohn’swort naloxegol

decreases exposure

Severe Theoretical
stjohn’swort neratinib

decreases exposure

Severe Theoretical
stjohn’swort nilotinib

decreases exposure

Severe Theoretical
stjohn’swort nirmatrelvirboostedwithritonavir

decreases exposure

Severe Theoretical
stjohn’swort olaparib

decreases exposure

Severe Theoretical
stjohn’swort osimertinib

decreases exposure

Severe Study
stjohn’swort paclitaxel

decreases exposure

Severe Study
stjohn’swort palbociclib

decreases exposure

Severe Theoretical
stjohn’swort panobinostat

decreases exposure

Severe Theoretical
stjohn’swort pemigatinib

decreases exposure

Severe Study
stjohn’swort phenobarbital

decreases concentration

Severe Theoretical
stjohn’swort phenytoin

decreases concentration

Severe Theoretical
stjohn’swort pibrentasvir

decreases exposure

Severe Study
stjohn’swort piperaquine

decreases concentration

Severe Theoretical
stjohn’swort ponatinib

decreases exposure

Severe Theoretical
stjohn’swort primidone

decreases concentration

Severe Theoretical
stjohn’swort ranolazine

decreases exposure

Severe Study
stjohn’swort regorafenib

decreases exposure

Severe Study
stjohn’swort relugolix

decreases exposure

Severe Study
stjohn’swort ribociclib

decreases exposure

Severe Study
stjohn’swort rimegepant

decreases exposure

Severe Theoretical
stjohn’swort selpercatinib

decreases exposure

Severe Study
stjohn’swort selumetinib

decreases exposure

Severe Study
stjohn’swort sofosbuvir

decreases exposure

Severe Study
stjohn’swort taxanes

decreases exposure

Severe Theoretical
stjohn’swort temsirolimus

decreases concentration

Severe Theoretical
stjohn’swort tenofoviralafenamide

decreases exposure

Severe Theoretical
stjohn’swort tezacaftor

decreases exposure

Severe Theoretical
stjohn’swort theactivemetaboliteoffostemsavir

decreases exposure

Severe Study
stjohn’swort thrombininhibitors

decreases exposure

Severe Study
stjohn’swort tiagabine

decreases exposure

Severe Theoretical
stjohn’swort tivozanib

decreases exposure

Severe Study
stjohn’swort tolvaptan

decreases exposure

Severe Theoretical
stjohn’swort tucatinib

decreases exposure

Severe Theoretical
stjohn’swort vandetanib

decreases exposure

Severe Study
stjohn’swort velpatasvir

decreases exposure

Severe Theoretical
stjohn’swort vemurafenib

decreases exposure

Severe Study
Prev 1 ... 16 17 18 19 Next
944 interactions
Important: This database uses data from the British National Formulary (BNF 85). It is for informational purposes only and is not a substitute for professional medical advice.